These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24857397)

  • 1. Effects of levothyroxine on growth hormone (gh) sensitivity in children with idiopathic short stature.
    García RJ; Iñiguez G; Gaete X; Linares J; Ocaranza P; Avila A; Roman R; Cassorla F
    Growth Horm IGF Res; 2014 Aug; 24(4):119-22. PubMed ID: 24857397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of supplementation of thyroid hormone on treatment of idiopathic short-stature children during therapy with recombinant human growth hormone.
    Wang W; Jiang S; Cui Z; Luo X; Shi L; Zheng H
    Front Med; 2018 Oct; 12(5):580-585. PubMed ID: 29623516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of growth hormone treatment on height in children with idiopathic short stature.
    Jeong HR; Shim YS; Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
    Smyczynska J; Hilczer M; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IGF-I response to growth hormone is related to body mass index in short children with normal weight.
    Roman R; Iniguez G; Lammoglia JJ; Avila A; Salazar T; Cassorla F
    Horm Res; 2009; 72(1):10-4. PubMed ID: 19571554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormone-deficient boys treated with growth hormone.
    Kjellberg H; Wikland KA
    Eur J Orthod; 2007 Jun; 29(3):243-50. PubMed ID: 17513878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Nierop AF; Gustafsson J; Bosaeus I; Fors H; Hochberg Z; Dahlgren J
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):346-54. PubMed ID: 20455890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM; Sun XJ; Shao P
    Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
    Lanes R; Jakubowicz S
    J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature.
    Lee JM; Davis MM; Clark SJ; Hofer TP; Kemper AR
    Arch Pediatr Adolesc Med; 2006 Mar; 160(3):263-9. PubMed ID: 16520445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
    Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study.
    Attie KM; Carlsson LM; Rundle AC; Sherman BM
    J Pediatr; 1995 Aug; 127(2):244-50. PubMed ID: 7636649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.
    Kim HS; Yang SW; Yoo HW; Suh BK; Ko CW; Chung WY; Lee KH; Hwang JS; Ji HJ; Ahn H; Kim DH
    Yonsei Med J; 2014 Jan; 55(1):53-60. PubMed ID: 24339287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.